Diaceutics PLC
LSE:DXRX

Watchlist Manager
Diaceutics PLC Logo
Diaceutics PLC
LSE:DXRX
Watchlist
Price: 121.5 GBX Market Closed
Market Cap: 102.6m GBX
Have any thoughts about
Diaceutics PLC?
Write Note

Diaceutics PLC
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Diaceutics PLC
Cost of Revenue Peer Comparison

Comparables:
ONT
G
GDR
ERGO
C4XD
HVO

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Diaceutics PLC
LSE:DXRX
Cost of Revenue
-ÂŁ4m
CAGR 3-Years
-7%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
Oxford Nanopore Technologies PLC
LSE:ONT
Cost of Revenue
-ÂŁ79.2m
CAGR 3-Years
-6%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
G
Genedrive PLC
LSE:GDR
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Ergomed PLC
LSE:ERGO
Cost of Revenue
-ÂŁ90.2m
CAGR 3-Years
-31%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
C4X Discovery Holdings PLC
LSE:C4XD
Cost of Revenue
-ÂŁ16k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
hVIVO PLC
LSE:HVO
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Diaceutics PLC's Cost of Revenue?
Cost of Revenue
-4m GBP

Based on the financial report for Dec 31, 2023, Diaceutics PLC's Cost of Revenue amounts to -4m GBP.

What is Diaceutics PLC's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-2%

Over the last year, the Cost of Revenue growth was -45%. The average annual Cost of Revenue growth rates for Diaceutics PLC have been -7% over the past three years , -2% over the past five years .

Back to Top